Dystrophin involvement in peripheral circadian SRF signalling

Area of Science:

• Muscle physiology and molecular biology
• Circadian biology and neuroscience

Background:

• Duchenne muscular dystrophy results from dystrophin absence, impacting muscle contraction.
• Dystrophin interacts with F-actin, a key component of the RhoA-actin-serum-response-factor (SRF) pathway involved in circadian signaling.

Purpose of the Study:

• To investigate the hypothesis that dystrophin loss causes circadian deficits.
• To explore the role of dystrophin in the RhoA-actin-SRF pathway and its impact on circadian signaling in peripheral tissues.

Main Methods:

• Analysis of RhoA-actin-SRF pathway alterations in dystrophin-deficient myotubes and mouse models.
• Assessment of F/G-actin ratios, MRTF levels, and gene expression (core-clock, target genes, circadian genes) in patient muscle biopsies.
• Examination of dystrophin presence in the suprachiasmatic nucleus (SCN) of dystrophic mice and evaluation of their circadian locomotor behavior.

Main Results:

• Demonstrated alterations in the RhoA-actin-SRF pathway in dystrophin-deficient models.
• Observed reduced F/G-actin ratios, altered MRTF levels, and dysregulated clock gene expression in Duchenne patient muscle.
• Confirmed dystrophin absence in the SCN of dystrophic mice, correlating with disrupted circadian behavior.

Conclusions:

• Dystrophin is a crucial component of the RhoA-actin-SRF pathway.
• Dystrophin acts as a novel mediator of circadian signaling in peripheral tissues.
• Loss of dystrophin leads to circadian dysregulation, contributing to Duchenne muscular dystrophy pathology.